Asensus Surgical, Inc.
ASXC
AMEX
| Weiss Ratings | ASXC - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | ASXC - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ASXC - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.67 | |||
| Price History | ASXC - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -- | |||
| 52-Week Low % Change | -- | |||
| Price | ASXC - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.40 | |||
| 52-Week Low Price | $0.17 | |||
| 52-Week Low Price (Date) | Aug 14, 2024 | |||
| 52-Week High Price (Date) | Sep 07, 2023 | |||
| Valuation | ASXC - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | -- | |||
| Enterprise Value | 92.26M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.31 | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 9.64 | |||
| Price/Book (Q) | -8.38 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | -- | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | ASXC - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 272.32M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ASXC - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 919 765 8400 | |||
| Address | 1 TW Alexander Drive Durham, NC 27703 | |||
| Website | www.asensus.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | ASXC - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -723.07% | |||
| Profit Margin | -850.75% | |||
| Management Effectiveness | ASXC - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -76.18% | |||
| Return on Equity | -- | |||
| Income Statement | ASXC - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 9.85M | |||
| Total Revenue (TTM) | 9.85M | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -3.00M | |||
| EBITDA (TTM) | -67.47M | |||
| EBIT (TTM) | -71.22M | |||
| Net Income (TTM) | -83.80M | |||
| Net Income Avl. to Common (TTM) | -83.80M | |||
| Total Revenue Growth (Q YOY) | 104.16% | |||
| Earnings Growth (Q YOY) | -24.62% | |||
| EPS Diluted (TTM) | -0.31 | |||
| EPS Diluted Growth (Q YOY) | -9.74% | |||
| Balance Sheet | ASXC - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 7.78M | |||
| Cash Per Share (Q) | $0.03 | |||
| Total Current Assets (Q) | 19.44M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -11.33M | |||
| Current Ratio (Q) | 0.487 | |||
| Book Value Per Share (Q) | -$0.04 | |||
| Total Assets (Q) | 38.50M | |||
| Total Current Liabilities (Q) | 39.92M | |||
| Total Debt (Q) | 5.12M | |||
| Total Liabilities (Q) | 49.83M | |||
| Total Common Equity (Q) | -11.33M | |||
| Cash Flow | ASXC - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 31.09M | |||
| Cash from Financing (TTM) | 25.81M | |||
| Net Change in Cash (TTM) | 270.00K | |||
| Levered Free Cash Flow (TTM) | -1.87M | |||
| Cash from Operations (TTM) | -56.65M | |||
